TNFSF13 and central nervous system cancer: Expectedly, the area under the curve (AUC) were 79.8% in TCGA dataset and 69.2% in CGGA dataset (Figure 1D), which suggested that TNFSF13 might be a potential biomarker in the developing progress of glioma (46).